BCRX
BIOCRYST PHARM
Health Care·Biotechnology·UNITED STATES
$9.96
MCap $2.5B
as of 2026-09-04
Total
B3w
Fund
B3w
Quant
B9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.41
Sentiment 78.9%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$9.96
Adaptive Mean
$10.04
-0.08 vs mean
Adaptive σ
0.10
MIDOS BB
$9.84 – $10.24
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+2.22
ROE
—
Z —
Rev Gr
33.6%
Z -0.24
EPS Gr
1400.0%
Z +0.17
OPM Gr
26.9%
Z +6.91
FCF Yld
12.7%
Z +1.06
EPS Surp
0.5%
Z +4.59
EPS 3mo Δ
-28.1%
Z +0.81
Fwd P/E
10.60
Z —
PEGY
0.01
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
9.04
Q6M
3.12
Q12M
2.28
MA 30/100
1.039
Bullish (MA30 > MA100)
α (Jensen)
0.7192
β (12M)
0.57
σ (12M)
0.477
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
100%
Q Percentile
61%
Divergence
+39.0
Tier
RELOAD — ACT
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
1.4
RS Pctl
62%
RS Decile
D7
Persistence
3w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.